Evidence map›Paper›PMID 31315705›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2019

Extensively drug-resistant tuberculosis 'hotspots' and sociodemographic associations in Durban, South Africa.

M L Peterson, N R Gandhi, J Clennon, K N Nelson, N Morris, N Ismail, S Allana, A Campbell, J C M Brust, S C Auld and 4 more

Abstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

M L PetersonEmory University Rollins School of Public Health, Atlanta, Georgia.
N R GandhiEmory University Rollins School of Public Health, Atlanta, Georgia, Emory University School of Medicine, Atlanta, Georgia, USA.
J ClennonEmory University Rollins School of Public Health, Atlanta, Georgia.
K N NelsonEmory University Rollins School of Public Health, Atlanta, Georgia.
N MorrisEnvironment and Health Research Unit, South African Medical Research Council, Johannesburg.
N IsmailNational Institute for Communicable Diseases, Johannesburg, University of Pretoria, Pretoria, South Africa.
S AllanaEmory University Rollins School of Public Health, Atlanta, Georgia.
A CampbellEmory University Rollins School of Public Health, Atlanta, Georgia.
J C M BrustAlbert Einstein College of Medicine, Bronx, New York.
S C AuldEmory University Rollins School of Public Health, Atlanta, Georgia, Emory University School of Medicine, Atlanta, Georgia, USA.
B MathemaColumbia University Mailman School of Public Health, New York, New York, USA.
K MlisanaNational Health Laboratory Service, Durban, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
P MoodleyNational Health Laboratory Service, Durban.
N S ShahEmory University Rollins School of Public Health, Atlanta, Georgia, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HARRIS GOLDSTEIN · 2017 to 2026
$28.3M
CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patientsUL1TR002556 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, KIM, MIMI Y · 2018 to 2022
$26.7M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Role of antigen-specific T cell responses in the control of TBU19AI111211 · NIAID · EMORY UNIVERSITY · PI RENGARAJAN, JYOTHI · 2014 to 2020
$20.1M
The Emory Training Program in Lung HealthT32HL116271 · NHLBI · EMORY UNIVERSITY · PI BROWN, LOU ANN S, GUIDOT, DAVID MARSHALL · 2013 to 2022
$4.2M
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TBR01AI087465 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2010 to 2014
$3.9M
The Role of Casual Contact and Migration in XDR TB Transmission in South Africa: a Geospatial, Genomic and Social Network StudyR01AI138646 · NIAID · EMORY UNIVERSITY · PI MLISANA, KOLEKA P, SHAH, NIPPIE SARITA · 2018 to 2022
$3.8M
Transmission of HIV-Associated XDR TB in Rural South AfricaR01AI089349 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2010 to 2014
$3.7M
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global HealthK24AI114444 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2014 to 2023
$1.8M
Impact of HIV infection on early responses to TB exposureK23AI134182 · NIAID · EMORY UNIVERSITY · PI AULD, SARA · 2018 to 2023
$972k
Integrated, Home-based Treatment for MDR TB and HIV in Rural South AfricaK23AI083088 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BRUST, JAMES C M · 2010 to 2014
$665k
NCATS NIH HHS UL1 TR001073NCATS NIH HHS UL1 TR002556NHLBI NIH HHS T32 HL116271NIAID NIH HHS K23 AI083088NIAID NIH HHS K23 AI134182NIAID NIH HHS K24 AI114444NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI124414NIAID NIH HHS R01 AI087465NIAID NIH HHS R01 AI089349NIAID NIH HHS R01 AI138646NIAID NIH HHS U19 AI111211
6 · The paper itself

Abstract

<sec> <title>BACKGROUND</title> In KwaZulu-Natal, South Africa, the incidence of extensively drug-resistant tuberculosis (XDR-TB) is driven by the transmission of resistant strains. As data suggest that cases may be spatially clustered, we sought to identify 'hotspots' and describe these communities. </sec> <sec> <title>METHODS</title> We enrolled XDR-TB patients diagnosed from 2011 to 2014 in eThekwini. Global positioning system (GPS) coordinates for participant homes were collected and hotspots were identified based on population-adjusted XDR-TB incidence. The sociodemographic features of hotspots were characterised using census data. For a subset of participants, we mapped non-home XDR-TB congregate locations and compared these with results including only homes. </sec> <sec> <title>RESULTS</title> Among 132 participants, 75 (57%) were female and 87 (66%) lived in urban or suburban locations. Fifteen of 197 census tracts were identified as XDR-TB hotspots with ≥95% confidence. Four spatial mapping methods identified one large hotspot in northeastern eThekwini. Hotspot communities had higher proportions of low educational attainment (12% vs. 9%) and unemployment (29.3% vs. 20.4%), and lower proportion of homes with flush toilets (36.4% vs. 68.9%). The case density shifted towards downtown Durban when congregate locations (e.g., workplaces) for 43 (33%) participants were mapped. </sec> <sec> <title>CONCLUSIONS</title> In eThekwini, XDR-TB case homes were clustered into hotspots with more poverty indicators than non-hotspots. Prevention efforts targeting hotspot communities and congregate settings may be effective in reducing community transmission. </sec>.

Indexed as

AdultCitiesCross-Sectional StudiesDemographyExtensively Drug-Resistant TuberculosisFemaleGeographic Information SystemsHumansIncidenceMaleSocioeconomic FactorsSouth AfricaTuberculosis, Pulmonary

Identifiers

PMID31315705
PMCPMC6641858

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.